Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/fda-grants-orphan-drug-designation-odd-status-to-neoimmunetechs-nt-i7-for-advanced-pancreatic-cancer-treatment-302047851.html
https://www.prnewswire.com/news-releases/neoimmunetech-welcomes-a-new-president-for-its-development-and-business-302034623.html
https://www.prnewswire.com/news-releases/neoimmunetech-and-imugene-enter-into-strategic-research-collaboration-to-improve-cancer-treatments-302011880.html
https://www.prnewswire.com/news-releases/fda-grants-orphan-drug-designation-to-neoimmunetechs-nt-i7-for-the-treatment-of-acute-radiation-syndrome-301993403.html
https://www.prnewswire.com/news-releases/neoimmunetech-to-present-new-advances-on-nt-i7-efineptakin-alfa-at-2023-sitc-annual-meeting-301938965.html
https://www.prnewswire.com/news-releases/neoimmunetech-welcomes-two-new-members-to-its-scientific-advisory-board-301885326.html
https://www.prnewswire.com/news-releases/neoimmunetech-to-partner-with-us-national-institute-of-allergy-and-infectious-diseases-niaid-national-institutes-of-health-nih-for-drug-development-in-acute-radiation-syndrome-ars-301712223.html
https://www.prnewswire.com/news-releases/new-evidence-of-neoimmunetechs-nt-i7-clinical-efficacy-in-combination-with-pembrolizumab-in-relapsedrefractory-rr-gastrointestinal-tumors-301673536.html
https://www.prnewswire.com/news-releases/neoimmunetech-to-present-first-data-on-nt-i7-efineptakin-alfa-in-combination-with-car-t-tisagenlecleucel-at-2022-ash-annual-meeting-301668788.html
https://www.prnewswire.com/news-releases/neoimmunetech-to-present-new-advances-on-nt-i7-efineptakin-alfa-at-2022-sitc-annual-meeting-301640635.html